{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:58Z","timestamp":1772119498617,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>No direct cost comparison has been conducted between percutaneous cryoablation (PCA) and robot-assisted partial nephrectomy (RAPN) for clinical T1a renal cell carcinoma (RCC) in Japan. This study aimed to compare their costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed data from 212 PCAs (including 155 with transcatheter arterial embolization) and 119 RAPN cases performed between December 2017 and May 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PCA patients were older with higher American Society of Anesthesiologists scores, Charlson Comorbidity Index, and history of previous RCC treatment, cardiovascular disease, and antithrombotic drug use than RAPN patients. PCA was associated with a significantly shorter procedure time and hospitalization duration with fewer major complications than those associated with RAPN. While PCA incurred a slightly lower total cost (1,123,000 vs. 1,155,000 yen), it had a significantly higher procedural cost (739,000 vs. 693,000 yen) and markedly worse total (\u2212\u00a093,000 vs. 249,000 yen) and procedural income-expenditure balance (\u2212\u00a0189,000 vs. 231,000 yen) than those of RAPN. After statistical adjustment, PCA demonstrated significantly higher total (difference: 114,000 yen) and procedural costs (difference: 72,000 yen), alongside significantly worse total (difference: \u2212\u00a0358,000 yen) and procedural income-expenditure balances (difference: \u2212\u00a0439,000 yen). The incremental cost-effectiveness ratio was more favorable for PCA than for RAPN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For high- risk patients, PCA demonstrated a safer option with shorter hospitalization duration than those of RAPN. Although PCA was more cost-effective, its higher procedural cost and unfavorable income-expenditure balance require careful evaluation, especially for large tumors that require three or more needles.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10147-025-02783-5","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:58:32Z","timestamp":1749211112000},"page":"1621-1630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Percutaneous cryoablation versus robot-assisted partial nephrectomy for small renal cell carcinoma: a retrospective cost analysis at Japanese single-institution"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-1961","authenticated-orcid":false,"given":"Mayu","family":"Uka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Bekku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Yamanoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Gobara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Umakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoo","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"2783_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00345-018-2286-7","volume":"36","author":"SH Rossi","year":"2018","unstructured":"Rossi SH, Klatte T, Usher-Smith J et al (2018) Epidemiology and screening for renal cancer. World J Urol 36:1341\u20131353. https:\/\/doi.org\/10.1007\/s00345-018-2286-7","journal-title":"World J Urol"},{"key":"2783_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1200\/JCO.2016.69.9645","volume":"35","author":"A Finelli","year":"2017","unstructured":"Finelli A, Ismaila N, Bro B et al (2017) Management of small renal masses: American society of clinical oncology clinical practice guideline. J Clin Oncol 35:668\u2013680. https:\/\/doi.org\/10.1200\/JCO.2016.69.9645","journal-title":"J Clin Oncol"},{"key":"2783_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier B, Porta C, Schmidinger M et al (2019) Renal cell carcinoma:\u00a0ESMO\u00a0clinical\u00a0practice\u00a0guidelines\u00a0for\u00a0diagnosis,\u00a0treatment\u00a0and\u00a0follow-up. Ann Oncol 30:706\u2013720. https:\/\/doi.org\/10.1093\/annonc\/mdz056","journal-title":"Ann Oncol"},{"key":"2783_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.eururo.2012.07.028","volume":"62","author":"S MacLennan","year":"2012","unstructured":"MacLennan S, Imamura M, Lapitan MC et al (2012) Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol 62:1097\u20131117. https:\/\/doi.org\/10.1016\/j.eururo.2012.07.028","journal-title":"Eur Urol"},{"key":"2783_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.urolonc.2011.08.004","volume":"31","author":"A Masson-Lecomte","year":"2013","unstructured":"Masson-Lecomte A, Yates DR, Hupertan V et al (2013) A prospective comparison of the pathologic and surgical outcomes obtained after elective treatment of renal cell carcinoma by open or robot-assisted partial nephrectomy. Urol Oncol 31:924\u2013929. https:\/\/doi.org\/10.1016\/j.urolonc.2011.08.004","journal-title":"Urol Oncol"},{"key":"2783_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1148\/radiol.2018180249","volume":"289","author":"DJ Breen","year":"2018","unstructured":"Breen DJ, King AJ, Patel N et al (2018) Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology 289:554\u2013561. https:\/\/doi.org\/10.1148\/radiol.2018180249","journal-title":"Radiology"},{"key":"2783_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1148\/radiol.2020192325","volume":"296","author":"J Morkos","year":"2020","unstructured":"Morkos J, Porosnicu Rodriguez KA, Zhou A et al (2020) Percutaneous cryoablation for stage 1 renal cell carcinoma: outcomes from a 10-year prospective study and comparison with matched cohorts from the national cancer database. Radiology 296:452\u2013459. https:\/\/doi.org\/10.1148\/radiol.2020192325","journal-title":"Radiology"},{"key":"2783_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s10147-020-01825-4","volume":"26","author":"H Gobara","year":"2021","unstructured":"Gobara H, Hiraki T, Iguchi T et al (2021) Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4\u00a0cm in diameter: a prospective observational study. Int J Clin Oncol 26:562\u2013568. https:\/\/doi.org\/10.1007\/s10147-020-01825-4","journal-title":"Int J Clin Oncol"},{"key":"2783_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s10147-022-02224-7","volume":"27","author":"H Gobara","year":"2022","unstructured":"Gobara H, Matsui Y, Uka M et al (2022) Perctaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinoma of 3\u00a0cm or larger: a prospective study. Int J Clin Oncol 27:1589\u20131595. https:\/\/doi.org\/10.1007\/s10147-022-02224-7","journal-title":"Int J Clin Oncol"},{"key":"2783_CR10","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.21873\/invivo.12413","volume":"35","author":"T Uemura","year":"2021","unstructured":"Uemura T, Kato T, Nagahara A et al (2021) Therapeutic and clinical outcomes of robot-assisted partial nephrectomy versus cryoablation for t1 renal cell carcinoma. In Vivo 35:1573\u20131579. https:\/\/doi.org\/10.21873\/invivo.12413","journal-title":"In Vivo"},{"key":"2783_CR11","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.3390\/cancers14235843","volume":"14","author":"S Kawaguchi","year":"2022","unstructured":"Kawaguchi S, Izumi K, Naito R et al (2022) Comparison of\u00a0clinical\u00a0outcomes\u00a0between\u00a0robot assisted partial nephrectomy and cryoablation in elderly patients with renal cancer. Cancers (Basel) 14:5843. https:\/\/doi.org\/10.3390\/cancers14235843","journal-title":"Cancers (Basel)"},{"key":"2783_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/bju.14530","volume":"23","author":"G Fraisse","year":"2019","unstructured":"Fraisse G, Colleter L, Peyronnet B et al (2019) Peri-operative and local control outcomes of robot-assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal score. BJU Int 23:632\u2013638. https:\/\/doi.org\/10.1111\/bju.14530","journal-title":"BJU Int"},{"key":"2783_CR13","doi-asserted-by":"publisher","first-page":"294.e9","DOI":"10.1016\/j.urolonc.2018.12.016","volume":"37","author":"R Bertolo","year":"2019","unstructured":"Bertolo R, Garisto J, Armanyous S et al (2019) Perioperative, oncological and functional outcomes after robotic partial nephrectomy vs. cryoablation in the elderly: a propensity score matched analysis. Urol Oncol 37:294.e9-294.e15. https:\/\/doi.org\/10.1016\/j.urolonc.2018.12.016","journal-title":"Urol Oncol"},{"key":"2783_CR14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1089\/end.2013.0192","volume":"27","author":"YS Tanagho","year":"2013","unstructured":"Tanagho YS, Bhayani SB, Kim EH et al (2013) Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience. J Endourol 27:1477\u20131486. https:\/\/doi.org\/10.1089\/end.2013.0192","journal-title":"J Endourol"},{"key":"2783_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1089\/end.2015.0183","volume":"30","author":"M Chehab","year":"2016","unstructured":"Chehab M, Friendlander JA, Handel J et al (2016) Percutaneous cryoablation vs partial nephrectomy: cost comparison of T1a tumors. J Endourol 30:170\u2013176. https:\/\/doi.org\/10.1089\/end.2015.0183","journal-title":"J Endourol"},{"key":"2783_CR16","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s00270-020-02732-x","volume":"44","author":"RG Garcia","year":"2021","unstructured":"Garcia RG, Kats M, Ealsarella PM et al (2021) Percutaneous cryoablation versus robot-assisted partial nephrectomy of renal T1a tumors: a single-center retrospective cost-effectiveness analysis. Cardiovasc Intervent Radiol 44:892\u2013900. https:\/\/doi.org\/10.1007\/s00270-020-02732-x","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2783_CR17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00330-022-09211-6","volume":"33","author":"X Wu","year":"2023","unstructured":"Wu X, Uhlig J, Shuch BM et al (2023) Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma. Eur Radiol 33:1801\u20131811. https:\/\/doi.org\/10.1007\/s00330-022-09211-6","journal-title":"Eur Radiol"},{"key":"2783_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien\u2013Dindo classification of surgical complications: five-year experience. Ann Surg 250:187\u2013196. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2","journal-title":"Ann Surg"},{"key":"2783_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11604-016-0569-8","volume":"34","author":"M Miyazaki","year":"2016","unstructured":"Miyazaki M, Iguchi T, Takaki H et al (2016) Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts. Jpn J Radiol 34:647\u2013656. https:\/\/doi.org\/10.1007\/s11604-016-0569-8","journal-title":"Jpn J Radiol"},{"key":"2783_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.juro.2016.04.081","volume":"196","author":"PM Pierorazio","year":"2016","unstructured":"Pierorazio PM, Johnson MH, Patel HD et al (2016) Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol 196:989\u2013999. https:\/\/doi.org\/10.1016\/j.juro.2016.04.081","journal-title":"J Urol"},{"key":"2783_CR21","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2208.01300","author":"T S\u0142oczy\u0144ski","year":"2022","unstructured":"S\u0142oczy\u0144ski T, Uysal D, Wooldridge JM (2022) Doubly robust estimation of local average treatment effects using inverse probability weighted regression adjustment. arXiv. https:\/\/doi.org\/10.48550\/arXiv.2208.01300","journal-title":"arXiv"},{"key":"2783_CR22","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","volume":"101","author":"AD Althouse","year":"2016","unstructured":"Althouse AD (2016) Adjust for multiple comparisons? It\u2019s not that simple. Ann Thorac Surg 101:1644\u20131645. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.11.024","journal-title":"Ann Thorac Surg"},{"key":"2783_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40471-017-0131-y","volume":"4","author":"JW Jackson","year":"2017","unstructured":"Jackson JW, Schmid I, Stuart EA (2017) Propensity scores in pharmacoepidemiology: beyond the horizon. Curr Epidemiol Rep 4:271\u2013280. https:\/\/doi.org\/10.1007\/s40471-017-0131-y. (Epub 2017 Nov 6)","journal-title":"Curr Epidemiol Rep"},{"key":"2783_CR24","doi-asserted-by":"publisher","DOI":"10.4135\/9781071802854","volume-title":"Practical propensity score methods using","author":"W Leite","year":"2016","unstructured":"Leite W (2016) Practical propensity score methods using. SAGE Publications Inc, Los Angeles. https:\/\/doi.org\/10.4135\/9781071802854"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02783-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T07:37:19Z","timestamp":1753429039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02783-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2783"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02783-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5904142\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}